STAT

STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, FDA syringe warnings, and more

This morning in the Pharmalittle roundup: We're reading about Medicare and obesity drugs, FDA syringe warnings, and more.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda so far appears quite modest. We, , , and . And what about you? If temperatures cooperate, this may be a fine time to enjoy the great outdoors — a walk in the woods or maybe a stroll along city streets. You could binge-watch something on the telly before streaming fees rise again. Or you could reach out to someone special. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks